Pilot study for the treatment of cutaneous neurofibromas in neurofibromatosis type 1 patients using topical sirolimus gel

被引：4
|
作者：
Wataya-Kaneda, Mari [1 ,2 ,10 ]
Watanabe, Yoshiyuki [3 ,4 ]
Nakamura, Ayumi [5 ]
Yamamoto, Kouji [6 ]
Okada, Kiyoshi [7 ]
Maeda, Shinichiro [8 ]
Nimura, Keisuke [9 ]
Saga, Kotaro
Katayama, Ichiro [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Dept Dermatol, Suita, Japan
[2] Osaka Univ, Grad Sch Med, Dept Neurocutaneous Med, Div Hlth Sci, Suita, Japan
[3] Osaka Univ, Grad Sch Med, Dept Radiol, Suita, Japan
[4] Shiga Univ Med Sci, Dept Radiol, Otsu, Japan
[5] Osaka Univ Hosp, Dept Pharm, Suita, Japan
[6] Yokohama City Univ, Sch Med, Dept Biostat, Yokohama, Japan
[7] Osaka Univ, Osaka Univ Hosp, Fac Med, Strateg Global Partnership Cross Innovat Initiat,G, Suita, Japan
[8] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Japan
[9] Osaka Univ, Grad Sch Med, Dept Genome Biol, Div Gene Therapy Sci, Suita, Japan
[10] Osaka Univ, Grad Sch Med, Dept Dermatol, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 88卷 / 04期
关键词：
D O I：
10.1016/j.jaad.2022.08.066
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：877 / 880
页数：4
相关论文
共 50 条
  • [41] Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1
    Sarin, Kavita Y.
    Bradshaw, Mark
    O'Mara, Chris
    Shahryari, Jahanbanoo
    Kincaid, John
    Kempers, Steven
    Tu, John H.
    Dhawan, Sunil
    Dubois, Janet
    Wilson, David
    Horwath, Patrice
    de Souza, Mark P.
    Powala, Christopher
    Kochendoerfer, Gerd G.
    Plotkin, Scott R.
    Webster, Guy F.
    Le, Lu Q.
    SCIENCE ADVANCES, 2024, 10 (18):
  • [42] Topical delivery of mitogen-activated protein kinase inhibitor binimetinib prevents the development of cutaneous neurofibromas in neurofibromatosis type 1 mutant mice
    Coulpier, Fanny
    Pulh, Pernelle
    Oubrou, Layna
    Naudet, Julie
    Fertitta, Laura
    Gregoire, Jean-Marc
    Bocquet, Arnaud
    Schmitt, Anne-Marie
    Wolkenstein, Pierre
    Radomska, Katarzyna J.
    Topilko, Piotr
    TRANSLATIONAL RESEARCH, 2023, 261 : 16 - 27
  • [43] Population Pharmacokinetics of Sirolimus in Pediatric Patients With Neurofibromatosis Type 1
    Scott, Jeffrey R.
    Courter, Joshua D.
    Saldaa, Shannon N.
    Widemann, Brigitte C.
    Fisher, Michael
    Weiss, Brian
    Perentesis, John
    Vinks, Alexander A.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (03) : 332 - 337
  • [44] A Review of Selumetinib in the Treatment of Neurofibromatosis Type 1-Related Plexiform Neurofibromas
    Anderson, Mary Kate
    Johnson, Meredith
    Thornburg, Lauren
    Halford, Zachery
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (06) : 716 - 726
  • [45] CO2 laser treatment of neurofibromas of patients with Neurofibromatosis type 1:: Five years experience
    Algermissen, B
    Müller, U
    Katalinic, D
    Berlien, HP
    LASERS IN SURGERY AND MEDICINE, 2002, : 58 - 58
  • [46] Neurofibromatosis Type 1 Presenting with Plexiform Neurofibromas in Two Patients: MRI Features
    Halefoglu, Ahmet Mesrur
    CASE REPORTS IN MEDICINE, 2012, 2012
  • [47] Identification of growth hormone receptor in localised neurofibromas of patients with neurofibromatosis type 1
    Cunha, KSG
    Barboza, EP
    da Fonseca, EC
    JOURNAL OF CLINICAL PATHOLOGY, 2003, 56 (10) : 758 - 763
  • [48] Phase II pilot study of imatinib mesylate in neurofibromatosis (NF1) patients with plexiform neurofibromas.
    Robertson, K. A.
    Bowers, D. C.
    Yang, F.
    Vik, T.
    Ho, C.
    Croop, J.
    Walsh, L. E.
    Hingtgen, C.
    Pradhan, K. R.
    Hutchins, G.
    Fletcher, J. W.
    Cohen, M.
    Edwards-Brown, M.
    Travers, J. B.
    Yu, M.
    Nalepa, G.
    Denne, S.
    Ingram, D.
    Clapp, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [49] QUALITY OF LIFE FOR PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 ASSOCIATED PLEXIFORM NEUROFIBROMAS (PNF)
    Lai, J.
    Beaumont, J. L.
    Jensen, S.
    VALUE IN HEALTH, 2017, 20 (09) : A727 - A727
  • [50] Management of head and neck plexiform neurofibromas in pediatric patients with neurofibromatosis type 1
    Wise, JB
    Cryer, JE
    Belasco, JB
    Jacobs, I
    Elden, L
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2005, 131 (08) : 712 - 718
12345